Tau-based therapeutics for Alzheimer's disease: active and passive immunotherapy.
about
Scalable Production of iPSC-Derived Human Neurons to Identify Tau-Lowering Compounds by High-Content Screening.A role for tau in learning, memory and synaptic plasticity.Prospects for strain-specific immunotherapy in Alzheimer's disease and tauopathies.Hepatitis B core VLP-based mis-disordered tau vaccine elicits strong immune response and alleviates cognitive deficits and neuropathology progression in Tau.P301S mouse model of Alzheimer's disease and frontotemporal dementia.
P2860
Tau-based therapeutics for Alzheimer's disease: active and passive immunotherapy.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年学术文章
@wuu
2016年学术文章
@zh
2016年学术文章
@zh-cn
2016年学术文章
@zh-hans
2016年学术文章
@zh-my
2016年学术文章
@zh-sg
2016年學術文章
@yue
2016年學術文章
@zh-hant
name
Tau-based therapeutics for Alzheimer's disease: active and passive immunotherapy.
@en
Tau-based therapeutics for Alzheimer's disease: active and passive immunotherapy.
@nl
type
label
Tau-based therapeutics for Alzheimer's disease: active and passive immunotherapy.
@en
Tau-based therapeutics for Alzheimer's disease: active and passive immunotherapy.
@nl
prefLabel
Tau-based therapeutics for Alzheimer's disease: active and passive immunotherapy.
@en
Tau-based therapeutics for Alzheimer's disease: active and passive immunotherapy.
@nl
P2093
P2860
P50
P356
P1433
P1476
Tau-based therapeutics for Alzheimer's disease: active and passive immunotherapy.
@en
P2093
Alberto Pilotto
Andrea Santamato
Antonio Daniele
Antonio Greco
Bruno P Imbimbo
Camilla Prete
Davide Seripa
Ilaria Galizia
Rosanna Tortelli
Vincenzo Solfrizzi
P2860
P304
P356
10.2217/IMT-2016-0019
P577
2016-09-01T00:00:00Z